The gain of N-cadherin expression in carcinomas has been shown to be important in the regulation of cell migration, invasion, and survival. Here, we show that N-cadherin mRNA expression in PC-3 prostate carcinoma cells is dependent on B 1 integrin-mediated cell adhesion to fibronectin and the basic helix-loop-helix transcription factor Twist1. Depletion of Twist1 mRNA by small interfering RNA resulted in decreased expression of both Twist1 and N-cadherin and the inhibition of cell migration. Whereas Twist1 gene expression was independent of B 1 integrin-mediated adhesion, Twist1 protein failed to accumulate in the nuclei of cells cultured in anchorage-independent conditions. The increased nuclear accumulation of Twist1 following cell attachment was suppressed by treatment with an inhibitor of Rho kinase or a B 1 integrin neutralizing antibody. The effect of Twist1 on induction of N-cadherin mRNA required an E-box cis-element located within the first intron (+2,627) of the N-cadherin gene. These data raise the possibility that integrin-mediated adhesion to interstitial matrix proteins during metastasis differentially regulates the nuclear/cytoplasmic translocation and DNA binding of Twist1, activating N-cadherin transcription. (Cancer Res 2006; 66(7): 3365-9) 
N-cadherin Gene Expression in Prostate Carcinoma Is Modulated by Integrin-Dependent Nuclear Translocation of Twist1 Introduction
The E-cadherin gene is a common target for transcriptional repression in epithelial malignancies and its regulation is considered a key step in the metastasis of carcinomas, including breast, and prostate (1) . With the silencing of E-cadherin transcription, adhesion molecules, such as N-cadherin, are induced during metastatic progression (2) . Aberrant N-cadherin expression in carcinomas has been shown to mediate antiapoptotic signaling pathways (3), the sustained signaling of the fibroblast growth factor receptor (4), and is required for cell migration during transforming growth factor h1 (TGFh1)-stimulated epithelial-to-mesenchymal transformation (5) . Although the mechanisms regulating the aberrant expression of N-cadherin in carcinoma progression remain unknown, the signaling of the GTPase RhoA has been shown to be necessary for N-cadherin induction by TGFh1 (6) . Recent evidence implicates Twist1, a basic helix-loop-helix transcription factor that is up-regulated in breast and prostate carcinomas, in the regulation of E-cadherin gene expression and the enhanced expression of mesenchymal genes (7, 8) . Twist has been shown to induce the expression of N-cadherin mRNA in human breast epithelial cells (7) but it is not known whether the expression of Twist1 directly activates N-cadherin transcription in carcinomas.
Prostate tumor cells undergo dynamic changes in integrin adhesion structures as they invade the interstitial extracellular matrix to metastasize. Integrins are a family of heterodimeric adhesion that bind to matrix proteins and activate specific intracellular signal transduction pathways, reorganize the actin cytoskeleton, and regulate the nuclear/cytoplasmic shuttling of transcription factors and kinases, such as Snail and extracellular signal-regulated kinase (9, 10) . A dynamic regulation of E-cadherin transcription by integrin-mediated cell adhesion has been shown through the downstream signaling of integrin-linked kinase (11) . In this study, we document a h 1 integrin-mediated induction of N-cadherin mRNA in PC-3 cells following adhesion to fibronectin. We show that Twist1 is necessary for N-cadherin transcriptional activation and that Twist1 nuclear accumulation is dependent on h 1 integrin-mediated adhesion. The regulation of N-cadherin expression by Twist1 is through a direct interaction with an E-box regulatory element located within the first intron of the N-cadherin gene.
Materials and Methods
Cell culture. PC-3 and MCF-7 cells (American Type Culture Collection, Manassas, VA) were cultured in DMEM supplemented with 10% fetal bovine serum (Hyclone, Logan, UT). For anchorage-independent culture, PC-3 cells were detached with 5 mmol/L EDTA in PBS and cultured for 2 to 3 days in serum-free medium at 10 5 cells/cm 2 in dishes coated with poly-2-hydroxyethylmethacrylate (Sigma, St. Louis, MO). The wound closure assay was carried out as previously described (5) with minor modifications.
Immunoblotting. Nuclei were isolated by swelling cells in hypotonic buffer [10 mmol/L Tris-HCl (pH 7.4), 1 mmol/L MgCl 2 , 1 mmol/L EDTA] for 30 minutes on ice and shearing cells in a Dounce homogenizer. Nuclei were pelleted and lysed in Laemmli SDS sample buffer with inhibitors. Western blotting was carried out as previously described (3) with antibodies to N-cadherin, E-cadherin, and h-catenin (Transduction Laboratories, San Diego, CA). Polyclonal anti-Twist (H-81 and N-19) and anti-Lamin A were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Densitometry was analyzed using Scion Image.
Twist1 small interfering RNA and overexpression. Small interfering RNA (siRNA) against the Twist1 target sequence 5V -ACUCCAAGAUGG-CAAGCUG-3V (nucleotides 857-875; NM000474) was purchased from Dharmacon (Lafayette, CO). siRNAs were added to cells at a final concentration of 50 nmol/L using the Oligofectamine transfection reagent (Invitrogen, Carlsbad, CA). A siRNA against the firefly luciferase target sequence 5V -CTTACGCTGAGTACTTCGA-3Vwas used as a negative control. The Twist1 expression vector contains the entire coding sequence of human Twist1 in pcDNA3.1 (12 Analysis of E-cadherin and N-cadherin mRNA levels. Quantitative real-time PCR primers were designed using the Primer 3 software (http:// frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) and are listed in Supplementary data. For each experimental sample, transcript levels were analyzed by the 2 ÀDDCt method. Transcript levels were normalized to RPL19 transcripts and were analyzed in triplicate. Northern blot analysis was completed as previously reported (13) . Gel shift analysis. Electrophoretic mobility shift assays were done as previously described (14) . Nuclear extracts (10 Ag) were incubated with 32 P-labeled double-stranded oligonucleotides for 15 minutes at room temperature in binding buffer [25 mmol/L HEPES (pH 7.5), 3 mmol/L MgCl 2 , 1 mmol/L EDTA, 0.5% Nonidet P40, 10% glycerol] with 1 Ag of poly(dI-dC). The N-cadherin first intron E-box sequence (+2,619 to +2,647) oligonucleotide was 5V -GGTTAAGTGCACCATGTGGATTGTACAACT-3V whereas the mutant sequence was 5V -GGTTAAGTGCACTTTGTGGATTG-TACAACT-3V . All unlabeled competitor oligonucleotides were added before incubation with labeled oligonucleotides whereas Twist1 antibodies were added 15 minutes after the labeled oligonucleotide. The Twist1 coding sequence was subcloned in-frame into pGEX2T and the expressed protein was affinity purified. DNA protein complexes were resolved on a 5% nondenaturing polyacrylamide gel.
N-cadherin promoter luciferase reporter assays. N-cadherin promoter activity was determined using constructs encoding the human N-cadherin 5V promoter (À860 to +20) in pGL3basic (Promega, Madison, WI), creating NP-860pGL3, or the 5Vpromoter (À860 to +20) and a region of the first intron from the human N-cadherin gene (+373 to +2,822 bp) downstream of luciferase in pGL3 (Supplementary data). Cells were transiently transfected in triplicate using the FuGENE 6 (Roche, Indianapolis, IN). The Dual Luciferase Kit (Promega) was used in luciferase assays according to the protocol of the manufacturer.
Results and Discussion
Reciprocal regulation of E-cadherin and N-cadherin. We used the prostate adenocarcinoma cell line PC-3, which expresses both E-cadherin and N-cadherin (3), to investigate the molecular events that contribute to the induction of N-cadherin. To examine whether the relative cadherin gene expression was reversible, total RNA was isolated from cells cultured in suspension as multicellular carcinoids, or from single cells attached to fibronectin. E-cadherin mRNA was high in suspended cells and decreased when the cells attached to a fibronectin substrate (Fig. 1A ) . In contrast, N-cadherin mRNA was 4-fold lower when cells were cultured in suspension as compared with attached cells. The protein levels of E-cadherin and N-cadherin in cells cultured in both conditions recapitulated the cadherin transcript levels (Fig. 1B) . These results suggest matrix-dependent cell attachment and spreading are necessary for the dynamic regulation of E-cadherin and N-cadherin gene expression.
When suspended PC-3 carcinoids (Fig. 1C and D) were dissociated and replated onto a fibronectin substrate, the induction of N-cadherin mRNA level is 2-fold at 6 hours and maximal at 12 hours (Fig. 1E) . h 1 integrin colocalization with F-actin was a rapid event, visible at 30 minutes following attachment and spreading on fibronectin (Fig. 1F) . Activation of N-cadherin gene expression was dependent on h 1 integrin-mediated cell adhesion, as preincubation with a h 1 integrin function-blocking antibody, AIIB2 (15) , before adhesion abrogated the increase in N-cadherin mRNA (Fig. 1E ). The reexpression of h 1 integrin in h 1 integrin-null epithelial cells was shown to modulate cadherin gene expression and induce an epithelial-to-mesenchymal transformation (16) . Thus, h 1 integrinmediated signaling following cell attachment and spreading may be a mechanism regulating N-cadherin mRNA expression in epithelial tumors.
Twist1 loss affects N-cadherin expression. We next examined whether Twist1 was necessary for N-cadherin expression in PC-3 cells attached to fibronectin. Depletion of Twist1 mRNA with siRNA resulted in decreased expression of both Twist1 and N-cadherin transcripts ( Fig. 2A ) and protein levels (Fig. 2B) . Transfection of Twist1 siRNAs reduced the Twist1 mRNA levels to f60% and N-cadherin transcript levels to 50%. Twist1 protein levels were reproducibly reduced nearly 90% in each experiment and N-cadherin levels were 50% of the control samples. In contrast, treatment with a control luciferase siRNA did not alter levels of Twist1 or N-cadherin. These findings, together with previous studies, suggest that Twist1 is necessary for the expression of N-cadherin in carcinoma cells (7) .
Twist1 has been shown to control the migration of cancer cell lines through its ability to regulate mesenchymal gene expression (7, 8) . We were interested in whether Twist1 regulation of N-cadherin expression contributed to cell motility in wound closure assays. As shown in Fig. 2C , control PC-3 cells or cells treated with luciferase siRNA efficiently migrate into the wound. In contrast, cells treated with Twist1 siRNA have reduced migration into the wound, and cell migration is decreased by 50% (Fig. 2C and D) . N-cadherin has been shown to enhance cell migration during epithelialto-mesenchymal transformation (5) . To determine the contribution of N-cadherin to PC-3 cell migration, an N-cadherin adhesionblocking monoclonal antibody was added to cells following wounding. This resulted in a statistically significant 30% decrease in cell migration. These data are in agreement with previous studies of Twist1 expression and function in metastatic cancer cells (7, 8) and suggest that regulation of cell migration by Twist1 is, in part, through its role in induction of N-cadherin gene expression.
Twist1 nuclear accumulation is integrin-mediated. Because inhibition of h 1 integrin engagement decreased N-cadherin transcript levels, we determined whether changes in Twist1 transcript levels in anchorage-independent cells could account for the decrease in N-cadherin mRNA. Analysis of Twist1 mRNA levels showed no change in the transcript level in suspended cells or in adherent cells whereas N-cadherin expression was upregulated in adherent cells (Fig. 3A) . In comparison, the zinc finger transcriptional repressor Slug showed increased mRNA expression in adherent cells, which is consistent with its role in silencing E-cadherin gene expression in attached cells (17) . We next examined whether Twist1 was present in the nuclei of anchorage-independent cells by subcellular fractionation. Although the level of Twist1 mRNA did not change in suspended or adherent cells, Twist1 protein was absent from the nucleus in cells cultured in suspension (Fig. 3B) . When suspended cells were replated onto a fibronectin substrate, there was a rapid accumulation of Twist1 into the nucleus, which was maximal at 30 minutes. This translocation was inhibited by addition of the h 1 integrin neutralizing antibody, AIIB2 (Fig. 3B and C) . To examine the adhesiondependent signaling pathways downstream of the h 1 integrin that regulate Twist1 nuclear accumulation, cells were pretreated with inhibitors before cell attachment to fibronectin. An inhibitor of Rho-associated kinase, Y-27632, and the actin-destabilizing drugs latrunculin B and jasplakinolide inhibited the nuclear accumulation of Twist1 (Fig. 3C) . Consistent with the inhibition of Twist1 nuclear accumulation by Y-27632, latrunculin B, and jasplakinolide, the levels of N-cadherin were also reduced in attached and spread cells (Fig. 3D ). Together these results suggest that the regulation of N-cadherin transcript levels by cell adhesion is due to h 1 integrinmediated adhesion through increased nuclear Twist1 accumulation. h 1 integrin activation of Rho-associated kinase and actin dynamics link the extracellular microenvironment with nuclear signaling. Twist1 may therefore be a transcriptional activator modulating activity downstream of h 1 integrin during invasion and metastasis.
Twist1 controls N-cadherin promoter activity. To determine whether the induction of N-cadherin mRNA by Twist1 in PC-3 cells involves direct binding of Twist1 to a cis-element in the promoter of N-cadherin, we generated a luciferase reporter construct containing the À860 to +20 bp region of the human N-cadherin 5V proximal promoter (Fig. 4A) . This includes the previously described minimal basal core promoter region À335 to À18 bp (18) . Cotransfection of the 5VN-cadherin promoter construct NP860 (+860 to À20) and Twist1 showed no increase in promoter activity in PC-3 cells nor in the N-cadherin-and Twist1-negative breast cancer cell line MCF-7 (Fig. 4B) . This suggests that Twist1 has little direct or indirect effect on activity of the N-cadherin 5V proximal promoter. Of the two documented Drosophila Twist1 E-box ciselement sequences (CATATG or CATGTG; ref. 14), we found a potential E-box sequence CATGTG located within the first intron of the human N-cadherin gene at +2,627 to +2,632 bp. Incorporation of the +373 to +2,822 region of the N-cadherin first intron downstream of luciferase in the 5V N-cadherin promoter reporter construct resulted in Twist1-mediated increases in N-cadherin promoter activity (Fig. 4B) . Mutagenesis of the E-box sequence at +2,627 eliminated the ability of Twist1 to induce N-cadherin promoter activity. Electrophoretic mobility shift assays were then done to determine the ability of Twist1 to bind the putative Twist1 E-box element in the N-cadherin first intron. Nuclear extracts from PC-3 cells were used to determine whether endogenously expressed Twist1 could associate with the N-cadherin first intron E-box sequence. Three DNA-protein complexes (Fig. 4C, lane 2, C1 , C2, and C3) were formed when nuclear extracts from adherent cells were incubated with labeled N-cadherin E-box oligonucleotides. Addition of excess unlabeled wild-type E-box oligonucleotides efficiently competed for DNA-protein complex formation whereas excess mutant oligonucleotides (TTTGTG) did not inhibit complex formation (lanes 3 and 4, respectively). To define Twist1 as the nuclear protein associating with the putative Twist1 E-box sequence, Twist1 antibody was added to the binding reactions which resulted in a supershifted DNA-protein band (lane 5). As expected, nuclear extracts from PC-3 cells in suspension failed to bind to the Twist1 E-box oligonucleotides (lane 6). A glutathione S-transferase (GST)-Twist1 fusion protein formed a distinct DNAprotein complex when incubated with radiolabeled N-cadherin E-box oligonucleotides (Fig. 4C, lane 8) . This DNA-protein complex was eliminated when an excess of unlabeled wild-type oligonucleotides was added to binding reactions (Fig. 4C, lane 9) . In contrast, addition of an excess of mutant oligonucleotides (TTTGTG) did not inhibit complex formation (Fig. 4C, lane 10) , suggesting that Twist1 binds to the E-box sequence at +2,627 bp in the N-cadherin first intron. The tissue-specific regulation of E-cadherin gene expression was shown to involve both the first and second introns in vivo (19) . Whereas the sequences of the first and second introns of the E-cadherin and N-cadherin genes are quite dissimilar, it seems that the intronic regulation of gene expression has been conserved between these two type I cadherin genes.
Concurrent with the loss of E-cadherin mRNA expression, the gain of N-cadherin expression in epithelial malignancies has been shown to be important in the regulation of cell migration, invasion, and survival. We provide evidence of transcriptional regulation of N-cadherin mRNA expression in epithelial cancer cells through an E-box sequence located within the first intron of the N-cadherin gene. In gastric carcinoma progression, a correlation was also described between N-cadherin and Twist1 mRNA expression (20) . Twist1 immunolocalization correlates with an increased Gleason score in prostate cancer specimens and displays both nuclear and cytoplasmic accumulation (8) . Our work documents the h 1 integrin-mediated control of Twist1 nuclear accumulation and the transcriptional induction of N-cadherin mRNA. Moreover, blocking h 1 integrin cell adhesion was found to inhibit N-cadherin promoter activity when the Twist1 E-box cis-element is present (Fig. 4D ). Together these data indicate that Twist1 is a pivotal transcription factor that regulates the gene expression of N-cadherin during cancer metastasis through multiple mechanisms, including the direct transcriptional regulation of N-cadherin and the regulation of cell migration. (18) . B, N-cadherin promoter activity in MCF-7 and PC-3 cells cotransfected with empty vector (pcDNA3.1) or human Twist1. Luciferase reporter constructs carrying the human N-cadherin promoter sequences: 5Vproximal promoter (NP860 ), 5Vproximal promoter with a wild-type region of the first intron of N-cadherin (NP860-WT Intron ), or 5Vproximal promoter and the segment of the N-cadherin first intron with a mutated E-box sequence (NP860-E-box Mutant ). Luciferase activity was normalized to the activity of the pTKRenilla control and represented as fold over control (pcDNA3.1) for each cell line. *, P < 0.005, MCF-7 and PC-3, respectively. C, electrophoretic mobility shift assay analysis with the N-cadherin first intron E-box oligonucleotides (WT ) and nuclear extracts from adherent cells (lanes 2-5 ) or suspended cells (lane 6 ) and GST-Twist (lanes 8-10 ) . Lanes 1 and 7, probe only; lane 2, adherent cell nuclear extract; lane 3, 50Â WT competitor; lane 4, 50Â mutant (MT) competitor (CATGTG to TTTGTG); lane 5, supershift with Twist antibody; lane 6, suspended PC-3 cell nuclear extract; lane 8, GST-Twist1 (100 ng); lane 9, 50Â WT competitor + GST-Twist1; lane 10, 50Â MT + GST-Twist1. D, h 1 integrin-mediated adhesion regulates N-cadherin promoter activation. Cells transiently transfected with N-cadherin luciferase constructs were treated with irrelevant IgG or h 1 integrin function-blocking monoclonal antibody (AIIB2). Columns, percent control where IgG was set as 100%.
